Sign in

CIK 0001676725 · Large accelerated filer

IDEAYA Biosciences, Inc.

Sign in to watch
Ticker
IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474268251
Phone
650-443-6209
Business address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale Chief Scientific Officer sold 28,500 shares at an average $36.24 ($1,032,884)
  4. 4 Planned sale President and CEO sold 175,000 shares at an average $42.27 ($7,397,291)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale See Remarks sold 2,000 shares at $46.02 ($92,045)
  11. 4 Planned sale President and CEO sold 99,372 shares at an average $45.24 ($4,495,550)
  12. 4 Planned sale President and CEO sold 628 shares at an average $45.00 ($28,260)
  13. 4 Planned sale See Remarks sold 2,000 shares at $42.03 ($84,050)
  14. 4 Planned sale See Remarks sold 2,000 shares at $38.01 ($76,026)
  15. 4 Planned sale President and CEO sold 75,000 shares at an average $40.15 ($3,010,882)
  16. 4 Planned sale Chief Legal Officer sold 10,000 shares at $35.04 ($350,371)
  17. 4 Planned sale President and CEO sold 75,000 shares at $35.03 ($2,627,618)
  18. 4 Planned sale See Remarks sold 2,000 shares at an average $34.00 ($68,002)
  19. 4 Planned sale Chief Legal Officer sold 5,163 shares at $30.09 ($155,360)
  20. 4 Planned sale Chief Legal Officer sold 1,000 shares at an average $30.01 ($30,005)

Page 3 of 10 · 197 filings